Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NUVL stock hub

Nuvalent, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NUVLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.3B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NUVL

In the news

Latest news · NUVL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-41.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-25.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NUVL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

USD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001861560
Company name	Nuvalent, Inc.
Country	United States
Country code	US
Cusip	670703107
Employees	228
Employees Change	86%
Employees Change Percent	60.56
Enterprise value	$7B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-29
Isin	US6707031075
Last refreshed	2026-05-10
Market cap	$8.3B
Market cap category	Mid-Cap
Price	$105
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	NUVL
Website	https://nuvalent.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.41%
P/B ratio	7.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-450.1M
Net Income Growth Years	0%
Profit Per Employee	$-2M
ROA	-22.51
Roa5y	-17.41
ROCE	-35.11
ROE	-41.19
Roe5y	-28.36
ROIC	-25.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	57.84%
Cagr3y	39.82%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$1.3B
Cash	$1.3B
Current Assets	$1.3B
Current Liabilities	$81.1M
Equity	$1.2B
Liabilities	$156.8M
Long Term Assets	$23.2M
Long Term Liabilities	$75.7M
Net Cash	$1.3B
Net Cash By Market Cap	$15.48
Net Cash Growth	19.96%
Net Debt Equity	$-1.1
Tangible Book Value	$1.2B
Tangible Book Value Per Share	$14.89
WACC	10.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	16.14
Net Working Capital	$-60.6M
Quick ratio	15.88
Working Capital	$1.2B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-15.54%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	57.79%
200-day SMA	95.47
3Y total return	173.38%
50-day SMA	101.8
50-day SMA vs 200-day SMA	50over200
All Time High	113.5
All Time High Change	-7.25%
All Time High Date	2024-09-16
All Time Low	7.09
All Time Low Change	1,384.91%
All Time Low Date	2022-05-19
ATR	3.95
Beta	1.15
Beta1y	0.68
Beta2y	0.91
Ch YTD	4.66
High	107.5
High52	113
High52 Date	2026-01-22
High52ch	-6.84%
Low	102.3
Low52	63.56
Low52 Date	2025-05-08
Low52ch	65.65%
Ma50ch	3.42%
Premarket Change Percent	-0.39
Premarket Price	$102
Price vs 200-day SMA	10.28%
RSI	54.6
RSI Monthly	63.64
RSI Weekly	56.93
Sharpe ratio	1.2x
Sortino ratio	2.08
Total Return	-15.54%
Tr YTD	4.66
Tr1m	2.96%
Tr1w	6.3%
Tr3m	1.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	16
Analyst Count Top	7
Analyst Price Target Top	$135
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.31
Operating Income	$-438.9M
Price target	$135
Price Target Change	$27.99
Price Target Change Top	$28.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49,031,647%
Float Percent	62.07%
Shares Insiders	2.52%
Shares Institutions	71.47%
Shares Out	78,997,915
Shares Qo Q	5.01%
Shares Yo Y	15.54%
Short Float	9.35%
Short Ratio	7.73
Short Shares	5.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	558,897.6x
Bv Per Share	14.89
Ch1m	2.96
Ch1w	6.3
Ch1y	57.79
Ch3m	1.63
Ch3y	173.4
Ch6m	12.78
Change	2.81%
Change From Open	2.03
Close	102.4
Days Gap	0.77
Dollar Volume	61,050,082.2
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$-438.9M
EPS	$-5.71
F Score	2
Financing CF	520,593,000
Fiscal Year End	December
Founded	2,017
Income Tax	$596,000
Investing CF	-168,908,000
Ipr	519.3
Iprfo	481.7
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	101.1
Ma150ch	4.09%
Ma20	104.1
Ma20ch	1.13%
Net CF	38,898,000
Next Earnings Date	2026-08-06
Open	103.2
Optionable	Yes
Position In Range	57.41
Post Close	105.3
Postmarket Change Percent	1.95
Postmarket Price	$107
Pre Close	102.4
Price Date	2026-05-08
Ptbv Ratio	7.08
Relative Volume	1.05x
Share Based Comp	95,002,000
Tr6m	12.78%
Us State	Massachusetts
Volume	579,883

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NUVL pay a dividend?

Capital-return profile for this ticker.

Performance

NUVL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NUVL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+71.5%

Float: +62.1% of shares outstanding

Insider ownership

+2.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NUVL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.6

Neutral momentum band

Price vs 200-day MA

+10.3%

50/200-day relationship not available

Beta (5Y)

1.15

Moves roughly with the market

Sharpe ratio

1.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NUVL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NUVL stock rating?

Nuvalent, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NUVL analysis?

The full report lives at /stocks/NUVL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NUVL?

The latest report frames NUVL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NUVL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.